Reference
Sharon Y, et al. Certolizumab pegol - Tumor necrosis factor inhibitor for refractory uveitis. American Journal of Ophthalmology Case Reports 18: Jun 2020. Available from: URL: 10.1016/j.ajoc.2020.100633
Rights and permissions
About this article
Cite this article
Multiple drugs. Reactions Weekly 2007, 266 (2024). https://doi.org/10.1007/s40278-024-58826-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-58826-x